Gleam
YC S23San Francisco, US · Founded 2023 · 4 employees · 2 known investors
Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.
AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaSArtificial IntelligenceHealthcareUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S23)
Gleam was founded in 2023 by Oliver Keh.
OK
Oliver Kehin𝕏CEO & FounderFounder and CEO of Gleam, an AI-assisted data entry platform for clinical research sites.
Investors · 2
In the news
Frequently asked questions
- What does Gleam do?
- Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.
- Who founded Gleam?
- Gleam was founded by Oliver Keh in 2023.
- Who are Gleam's investors?
- Gleam's investors include Focal Ventures, Y Combinator.
- Where is Gleam headquartered?
- Gleam is headquartered in San Francisco, US.